Características diferenciales de la hepatitis autoinmune en adultos mayores colombianos: estudio de cohorte

Authors

  • Gabriel Sebastian Díaz Ramírez Universidad de Antioquia
  • Omar Yesid Martínez Casas Universidad de Antioquia
  • Juan Ignacio Marín Zuluaga Hospital Pablo Tobón Uribe
  • Jorge Hernando Donado Gómez Hospital Pablo Tobón Uribe
  • Octavio Muñoz Maya Hospital Pablo Tobón Uribe
  • Oscar Santos Sánchez Hospital Pablo Tobón Uribe
  • Juan Carlos Restrepo Gutiérrez Hospital Pablo Tobón Uribe

DOI:

https://doi.org/10.22516/25007440.291

Keywords:

Autoinmune hepatitis, Latin América, elderly patients

Abstract

Introduction: Elderly patients with autoimmune hepatitis (AIH) are a special population because of predisposition mediated by the human leukocyte antigen (HLA) system. An indolent and progressive course of the disease has been described. No data are known for the Latin American population.

Objectives: This study compares clinical presentations, diagnoses, treatments, responses to treatment and course of disease for AIH patients who are over 65 years of age with those of AIH patients who are under 65.

Methods: This is a retrospective cohort study of patients with HAI evaluated between January 2010 and December 2016. Statistical analyses used SPSS version 20.1.

Results: Two hundred fourteen patients were included. Elderly patients had hypertension (34.5% vs 15.1%, p = 0.011), dyslipidemia (20.7% vs 5.9%, p = 0.006) and cardiovascular disease (17.2% vs 2.7%, p = 0.001) more frequently than did the younger patients. In addition, the elderly had a higher frequency of cirrhosis confirmed histologically and radiologically (55.1% vs. 33.5%, p = 0.024) at the time of diagnosis. Older patients had a higher rate of biochemical remission resulting from treatment (100% vs 83.9%, p = 0.022). There were no differences in hepatic analyses, autoantibodies, type of pharmacological treatment received, relapses, adverse effects related to treatment, requirements for liver transplantation and deaths.

Conclusion: AIH affects the Colombian adult population at all ages and should be considered in the diagnostic approach of elderly patients who have liver disease because this group has a higher frequency of cirrhosis at the time of diagnosis. Early diagnosis is important because treatment is effective and well tolerated.

Downloads

Download data is not yet available.

Author Biographies

Gabriel Sebastian Díaz Ramírez, Universidad de Antioquia

Hepatología clínica. Universidad de Antioquia, Medellín

Omar Yesid Martínez Casas, Universidad de Antioquia

Hepatología clínica. Universidad de Antioquia, Medellín

Juan Ignacio Marín Zuluaga, Hospital Pablo Tobón Uribe

Grupo gastro-hepatología, Universidad de Antioquia. Unidad de hepatología y trasplante hepático, Hospital Pablo Tobón Uribe

Jorge Hernando Donado Gómez, Hospital Pablo Tobón Uribe

Grupo gastro-hepatología, Universidad de Antioquia. Unidad de epidemiología, Hospital Pablo Tobón Uribe

Octavio Muñoz Maya, Hospital Pablo Tobón Uribe

Grupo gastro-hepatología, Universidad de Antioquia. Unidad de hepatología y trasplante hepático, Hospital Pablo Tobón Uribe

Oscar Santos Sánchez, Hospital Pablo Tobón Uribe

Grupo gastro-hepatología, Universidad de Antioquia. Unidad de hepatología y trasplante hepático, Hospital Pablo Tobón Uribe

Juan Carlos Restrepo Gutiérrez, Hospital Pablo Tobón Uribe

Grupo gastro-hepatología, Universidad de Antioquia. Unidad de hepatología y trasplante hepático, Hospital Pablo Tobón Uribe

References

Waldeström J. Leber, Blut proteine und Nahrungseiweiss. DischZ Verdan Stoff’Wechselkr. 1950;15:113-6.

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015 Oct;63(4):971-1004. https://doi.org/10.1016/j.jhep.2015.06.030. Epub 2015 Sep 1. Erratum in: J Hepatol. 2015 Dec;63(6):1543-4.

Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease. World J Gastroenterol. 2008 Jun 7;14(21):3360-7. https://doi.org/10.3748/wjg.14.3360.

Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006 Oct;45(4):575-83. https://doi.org/10.1016/j.jhep.2006.04.007.

Chen J, Eslick GD, Weltman M. Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly. Aliment Pharmacol Ther. 2014 Jan;39(2):117-24. https://doi.org/10.1111/apt.12563.

Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 Apr 12;4:18017. https://doi.org/10.1038/nrdp.2018.17.

Czaja AJ. Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis. 2009 Aug;29(3):315-30. https://doi.org/10.1055/s-0029-1233530.

Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006 Mar;43(3):532-8. https://doi.org/10.1002/hep.21074.

Schramm C, Kanzler S, zum Büschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol. 2001 May;96(5):1587-91. https://doi.org/10.1016/S0002-9270(01)02345-0.

Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, et al. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment Pharmacol Ther. 2005 May 15;21(10):1273-7. https://doi.org/10.1111/j.1365-2036.2005.02488.x.

Czaja AJ. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging. 2008;25(3):219-39. https://doi.org/10.2165/00002512-200825030-00005.

Verslype C, George C, Buchel E, Nevens F, van Steenbergen W, Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther. 2005 Mar 15;21(6):695-9. https://doi.org/10.1111/j.1365-2036.2005.02403.x.

Parker DR, Kingham JG. Type I autoimmune hepatitis is primarily a disease of later life. QJM. 1997 Apr;90(4):289-96. https://doi.org/10.1093/qjmed/90.4.289.

Newton JL, Burt AD, Park JB, Mathew J, Bassendine MF, James OF. Autoimmune hepatitis in older patients. Age Ageing. 1997 Nov;26(6):441-4. https://doi.org/10.1093/ageing/26.6.441.

Miyake Y, Iwasaki Y, Takaki A, Kobashi H, Sakaguchi K, Shiratori Y. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Intern Med. 2007;46(24):1945-9. https://doi.org/10.2169/internalmedicine.46.0420.

Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008 Jul;48(1):169-76. https://doi.org/10.1002/hep.22322.

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999 Nov;31(5):929-38. https://doi.org/10.1016/S0168-8278(99)80297-9.

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007 Oct 16;147(8):W163-94. https://doi.org/10.7326/0003-4819-147-8-200710160-00010-w1.

Díaz-Ramírez GS, Marín-Zuluaga JI, Donado-Gómez JH, Muñoz-Maya O, Santos-Sánchez Ó, Restrepo-Gutiérrez JC. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study. Gastroenterol Hepatol. 2018 Feb;41(2):87-96. https://doi.org/10.1016/j.gastrohep.2017.09.003.

Czaja AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol. 2013 Jul;27(7):417-23. https://doi.org/10.1155/2013/198070.

Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010 Jun;51(6):2040-8. https://doi.org/10.1002/hep.23588.

Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31. https://doi.org/10.1016/S1542-3565(04)00246-0.

Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005 Jul;42(1):53-62. https://doi.org/10.1002/hep.20732.

Watad A, Bragazzi NL, Adawi M, Amital H, Toubi E, Porat BS, et al. Autoimmunity in the Elderly: Insights from Basic Science and Clinics – A Mini-Review. Gerontology. 2017;63(6):515-523. https://doi.org/10.1159/000478012.

Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G. How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis. 2012;2012:251730. https://doi.org/10.1155/2012/251730.

Schwab R, Russo C, Weksler ME. Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans. Eur J Immunol. 1992 Nov;22(11):2989-93. https://doi.org/10.1002/eji.1830221134.

De Paoli P, Battistin S, Santini GF. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immunol Immunopathol. 1988 Sep;48(3):290-6. https://doi.org/10.1016/0090-1229(88)90022-0

Ben-Yehuda A, Weksler ME. Immune senescence: mechanisms and clinical implications. Cancer Invest. 1992;10(6):525-31. https://doi.org/10.3109/07357909209024815

Duarte-Rey C, Pardo AL, Rodríguez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev. 2009 Feb;8(4):325-31. https://doi.org/10.1016/j.autrev.2008.11.005

Published

2019-07-02

How to Cite

Díaz Ramírez, G. S., Martínez Casas, O. Y., Marín Zuluaga, J. I., Donado Gómez, J. H., Muñoz Maya, O., Santos Sánchez, O., & Restrepo Gutiérrez, J. C. (2019). Características diferenciales de la hepatitis autoinmune en adultos mayores colombianos: estudio de cohorte. Revista Colombiana De Gastroenterología, 34(2), 135–143. https://doi.org/10.22516/25007440.291

Issue

Section

Originals articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code